Fundamentals in Urology Webcast (2019): PSA, Urine Markers and the Science of Cancer Screening

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

This course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. New topics for this year include Complications of Urologic Surgery and Office Evaluation of the Patient Presenting with Incontinence and Surgical Management of Incontinence. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners.

Target Audience

  • Residents
  • Allied Health Professionals
  • Urologists

Learning Objectives

Upon completion of this course, participants will be able to:

Stones, Urodynamics and Inflammation

  1. Describe the basic pathophysiology of nephrolithiasis
  2. Identify the indications and options for the medical evaluation of recurrent and first time stone formers.
  3. Establish an effective algorithm for the medical management of nephrolithiasis.
  4. Identify the true incidence of IC/BPS and CP/CPPS in the US population.
  5. Identify what is currently believed about the pathophysiology of chronic pelvic pain.
  6. Describe how to use the AUA guidelines to develop a treatment plan for patients with IC/BPS and CP/CPPS.
  7. Review current research in pelvic pain and possible new treatment options.
  8. Apply knowledge of lower urinary tract function and electronic measurement of pressure, flow and electromyography to performance of a multichannel urodynamic test including prestudy uroflowmetry, filling cystometrogram and voiding pressure flow study.

Pediatrics

  1. Review salient concepts of vesicoureteral reflux, urinary tract obstruction and cryptorchidism with urology residents in the early stages of their urology residency training curriculum.
  2. Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters.
  3. Identify clinical situations that may be encountered if aberrant development occurs in any of the above organ systems.

Complications of Urologic Surgery and Imaging for Urologists

  1. Distinguish when the presence of bacteria or fungi in the urinary tract need to be treated, and when they don’t.
  2. Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters.

BPH and Science of Minimally Invasive Surgery and Infertility and Erectile Dysfunction

  1. Identify the medical therapies designed to address benign enlargement of the prostate.
  2. Explain the basic physics underlying laser energy, physiologic changes attributable to pneumoperitoneum, and mechanisms to improve outcomes of shock wave lithotripsy.
  3. Explain male reproductive anatomy and physiology.
  4. Describe a basic clinical overview of male reproductive medicine and surgery.

Prostate Cancer

  1. Describe the history of M1 Prostate cancer therapies.
  2. Identify basics in ADT management.
  3. Discuss basic science and clinical outcomes of new therapies.

Bladder Neurobiology and Pelvic Organ Prolapse

  1. Review the anatomy and physiology of the lower urinary tract as it relates to bladder storage and voiding.
  2. Describe the innervation of the lower urinary tract and the principle mechanisms by which the central and peripheral nervous systems control urine storage and micturition.
  3. Explain the pathophysiological findings related to bladder dysfunction in specific neurological conditions.
  4. Discuss the pathophysiology, evaluation strategy, and treatment options for overactive bladder.

Bladder Cancer and Bowel Diversions

  1. Discuss the rationale behind selection of segment of bowel used in urinary diversion.
  2. Explain the long term consequences of metabolic changes after urinary diversion and how to mitigate them.
  3. Describe the surgical principle of compliance and how it relates to surgical technique.

Adrenal Disorders and Kidney Cancer

  1. Define the fundamentals of adrenal anatomy and physiology integrate into the care of the urologic patient.
  2. Describe the genetic basis and current clinical and surgical management of all types of localized as well as advanced kidney cancer.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
06/12/2019
Course expires: 
06/12/2022
Part of: 
Fundamentals in Urology Webcast (2019)
Rating: 
0

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and/or listening to the podcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 1.00 hours

Release Date: June, 2019
Expiration Date: June, 2022

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.